Related references
Note: Only part of the references are listed.
Article
Pathology
Angela N. Viaene et al.
Summary: Pediatric glial tumors have unique differences from adult glial tumors, with the integration of molecular information playing a significant role in prognosis and treatment implications. Given the complexity of the field, a practical approach to diagnosis involving molecular surrogate immunohistochemical stains and basic molecular studies is essential.
PEDIATRIC AND DEVELOPMENTAL PATHOLOGY
(2022)
Editorial Material
Clinical Neurology
Felix Sahm et al.
Review
Clinical Neurology
Tejus A. Bale et al.
Summary: The 2021 5th edition of the WHO Classification of Tumors of the Central Nervous System reflects the discovery of genetic alterations underlying many central nervous system (CNS) neoplasms. There have been substantial changes to CNS tumor classification, especially for pediatric low-grade gliomas and glioneuronal tumors (pLGG/GNTs). The new classification now classifies gliomas, glioneuronal tumors, and neuronal tumors into 6 families, with six newly recognized tumor types. This has implications for the treatment and molecular testing and interpretation of pLGG/LGNT.
Review
Clinical Neurology
David M. Meredith et al.
Summary: This article provides an update on CNS embryonal and non-meningothelial mesenchymal tumors, focusing on WHO changes and additions, as well as recent discoveries with diagnostic, prognostic, and therapeutic implications.
Review
Clinical Neurology
Benjamin T. Whitfield et al.
Summary: In the past decade, advancements in molecular profiling have significantly impacted the way cancer types, including primary brain tumors, are diagnosed, classified, and managed. Molecular alterations have allowed for a more refined classification of brain tumors, deviating from the traditional reliance on morphological characteristics. This shift towards molecular classification is evident in the 2021 WHO classification of central nervous system tumors. This review focuses on the recent updates regarding the classification of adult-type diffuse gliomas, which are highly infiltrative and mostly incurable malignancies of the central nervous system. The refinement of molecular criteria holds promise for improving the diagnosis, prognostication, and eventual treatment of these devastating tumors.
Review
Clinical Neurology
Catena Kresbach et al.
Summary: Ependymal neoplasms are a heterogeneous group of tumors that occur in different parts of the central nervous system. Recent advances in understanding the genetic and molecular characteristics of ependymal tumors have led to an improved classification system. New classification schemes based on global DNA methylation profiling have enhanced the prediction of patients' outcomes.
Review
Oncology
David N. Louis et al.
Summary: The fifth edition of the WHO Classification of Tumors of the Central Nervous System integrates molecular diagnostics into CNS tumor classification, introduces different approaches to tumor nomenclature and grading, and emphasizes the importance of integrated diagnoses and layered reports.
Editorial Material
Clinical Neurology
David N. Louis et al.
